Results 151 to 160 of about 129,510 (314)
Abstract Purpose This systematic review aims to evaluate and synthesize the existing literature on the interventions used for submacular haemorrhage (SMH), highlighting the controversies and differences in clinical practice. Method A systematic review was conducted following the PRISMA guidelines.
Salvador Pastor‐Idoate +6 more
wiley +1 more source
It is crucial to maintain the stability of transgene and its expression level. It seems the transformation method and the target organ can influence this instability.
Mahshid Amiri +3 more
doaj
Hemi-Orolingual Angioedema in a Patient With VEXAS Syndrome. [PDF]
eJHaem, Volume 7, Issue 1, February 2026.
Suárez EU +2 more
europepmc +2 more sources
A monoclonal antibody preventing binding of tissue-type plasminogen activator to fibrin: useful to monitor fibrinogen breakdown during t-PA infusion [PDF]
Paul Holvoet, HR Lijnen, D Collen
openalex +1 more source
Abstract Purpose To evaluate visual, anatomical and safety outcomes of aflibercept 8 mg in previously treated patients with neovascular age‐related macular degeneration (nAMD). Methods This retrospective study included nAMD patients switched to aflibercept 8 mg from prior anti‐VEGF therapies at Sahlgrenska University Hospital between February 2024 and ...
Imadeddin Abu Ishkheidem +5 more
wiley +1 more source
Linkage disequilibrium and haplotype analysis among eight novel single-nucleotide polymorphisms in the human tissue-type plasminogen activator (t-PA) gene [PDF]
Ichirou Nakazawa +4 more
openalex +1 more source
Bone marrow (BM) involvement in B‐cell non‐Hodgkin lymphoma (B‐NHL) is associated with poor prognosis, as the BM microenvironment provides a protective niche that promotes therapeutic resistance. We developed a simplified, automated and high‐throughput 3D BM co‐culture model that faithfully reproduces key tumour–stroma interactions.
Alex Zadro +12 more
wiley +1 more source
Role of β-Adrenergic Receptors on Nitric Oxide-Dependent Tissue-Type Plasminogen Activator (t-PA) Release in Normotensive Subjects and Hypertensive Patients [PDF]
Damiano Rizzoni +7 more
openalex +1 more source
Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?
Psychedelic drugs that activate 5‐HT2A receptors have been long used for cultural, medicinal and recreational purposes. Interest in psychedelics for treating psychiatric disorders has resurged recently and is well documented; less well recognised are their anti‐inflammatory properties. Growing evidence now demonstrates that psychedelics modulate immune
Omar Qureshi +10 more
wiley +1 more source

